AR106331A2 - N-BENZOIL-ESTAUROSPORINA, FORM II - Google Patents
N-BENZOIL-ESTAUROSPORINA, FORM IIInfo
- Publication number
- AR106331A2 AR106331A2 ARP160103121A ARP160103121A AR106331A2 AR 106331 A2 AR106331 A2 AR 106331A2 AR P160103121 A ARP160103121 A AR P160103121A AR P160103121 A ARP160103121 A AR P160103121A AR 106331 A2 AR106331 A2 AR 106331A2
- Authority
- AR
- Argentina
- Prior art keywords
- staurosporine
- benzoyl
- estaurosporina
- benzoil
- warm
- Prior art date
Links
- BMGQWWVMWDBQGC-IIFHNQTCSA-N midostaurin Chemical compound CN([C@H]1[C@H]([C@]2(C)O[C@@H](N3C4=CC=CC=C4C4=C5C(=O)NCC5=C5C6=CC=CC=C6N2C5=C43)C1)OC)C(=O)C1=CC=CC=C1 BMGQWWVMWDBQGC-IIFHNQTCSA-N 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 2
- 238000002405 diagnostic procedure Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
Landscapes
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se refiere a una forma cristalina II de N-benzoil-estaurosporina; a composiciones que la contienen; a procesos para su preparación; y al uso de la forma cristalina II de N-benzoil-estaurosporina en métodos de diagnóstico o en el tratamiento terapéutico de animales de sangre caliente, en especial seres humanos. A las formas amorfas de N-benzoil-estaurosporina; a composiciones que las contienen; a procesos para su preparación y al uso de la N-benzoil-estaurosporina amorfa en métodos de diagnóstico o en el tratamiento terapéutico de animales de sangre caliente, en especial seres humanos.It refers to a crystalline form II of N-benzoyl-staurosporine; to compositions containing it; to processes for its preparation; and the use of the crystalline form II of N-benzoyl-staurosporine in diagnostic methods or in the therapeutic treatment of warm-blooded animals, especially humans. To amorphous forms of N-benzoyl-staurosporine; to compositions containing them; to processes for its preparation and to the use of amorphous N-benzoyl-staurosporine in diagnostic methods or in the therapeutic treatment of warm-blooded animals, especially humans.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62534304P | 2004-11-05 | 2004-11-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR106331A2 true AR106331A2 (en) | 2018-01-03 |
Family
ID=38772207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160103121A AR106331A2 (en) | 2004-11-05 | 2016-10-13 | N-BENZOIL-ESTAUROSPORINA, FORM II |
Country Status (3)
| Country | Link |
|---|---|
| CN (2) | CN101665498A (en) |
| AR (1) | AR106331A2 (en) |
| ZA (1) | ZA200703298B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2327706A1 (en) * | 2009-11-30 | 2011-06-01 | Novartis AG | Polymorphous forms III and IV of N-benzoyl-staurosporine |
| CN112812129A (en) * | 2020-12-31 | 2021-05-18 | 浙江海正药业股份有限公司 | Novel crystalline form of midostaurin, process for its preparation and its use |
| CN119930649A (en) * | 2023-11-02 | 2025-05-06 | 福建科瑞药业有限公司 | MTL-II crystal form of midostaurin and its preparation method and application |
-
2005
- 2005-11-03 CN CN200910002292A patent/CN101665498A/en active Pending
- 2005-11-03 CN CN 200580037222 patent/CN101048416A/en active Pending
-
2007
- 2007-04-23 ZA ZA200703298A patent/ZA200703298B/en unknown
-
2016
- 2016-10-13 AR ARP160103121A patent/AR106331A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101048416A (en) | 2007-10-03 |
| ZA200703298B (en) | 2008-09-25 |
| CN101665498A (en) | 2010-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP12007431A (en) | ORGANIC COMPOUNDS | |
| UY30728A1 (en) | CRYSTAL SALTS AND FORMS OF 2-METHYL- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -QUINOLIN-1- IL-PHENYL] PROPIONITRILE | |
| HN2004000490A (en) | PROCEDURE FOR THE PREPARATION OF AN ORALLY ADMINISTRABLE SOLID PHARMACEUTICAL COMPOSITION | |
| HN2008000311A (en) | CRYSTAL FORMS OF 4-METHYL-N- [3- (4-METHYL-IMIDAZOL-1-IL) -5-TRIFLUOROMETIL-PHENYL] -3- (4-PIRIDIN-3-IL-PIRIMIDIN-2-ILAMINO) -BENZAMIDA | |
| CL2006001266A1 (en) | CRYSTALLINE SOLID FORMS I, II, III, IV AND V OF TIGECICLINE; PROCEDURE FOR THE PREPARATION OF CRYSTAL FORMS II, IV AND V; PHARMACEUTICAL COMPOSITION THAT INCLUDES CRYSTALLINE FORMS; AND ITS USE TO TREAT BACTERIAL INFECTIONS. | |
| UY27720A1 (en) | MONOCYCLIC AROILPIRIDINONES, | |
| CR8642A (en) | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS | |
| PT1506781E (en) | COMPOSITION FOR VAGINAL TREATMENT | |
| AR063923A1 (en) | SALTS OF ZOLEDRONIC ACID, PREPARATION PROCESSES AND COMPOSITIONS | |
| UY29459A1 (en) | ASTORAPINE MALEATE ORTHROCHEMICAL CRYSTAL FORM AND ITS USE IN THE TREATMENT OF MENTAL DISORDERS | |
| BRPI0912292A2 (en) | compositions and methods for the use of cells in the treatment of cardiac tissue. | |
| CL2011003144A1 (en) | Crystalline form e3 of atazanavir bisulfate; pharmaceutical composition comprising it; Useful for the treatment of diseases caused by retroviruses (divisional of the application 1057-05). | |
| CL2008002082A1 (en) | Compounds derived from 6-phenyl-1h-imidazo [4,5-c] pyridine-4-carbonitrile, inhibitors of cathepsin s and cathepsin k; pharmaceutical composition; and use in the treatment of osteoporosis, atherosclerosis, inflammation, among other diseases. | |
| CL2012002887A1 (en) | Pharmaceutical combination comprising compounds derived from substituted 2,3-dihydroimidazo [1,2-c] quinazoline, compounds derived from n- (2-arylamino) arylsulfonamide and optionally other additional pharmaceutical agents; pharmaceutical kit; treatment method; and its use for the treatment or prophylaxis of cancer. | |
| UY29170A1 (en) | REPLACED ADENINS AND USES OF THE SAME | |
| UY31758A (en) | ORVEPITANT MALEATE ANHYDRA CRYSTAL FORM | |
| AR106331A2 (en) | N-BENZOIL-ESTAUROSPORINA, FORM II | |
| PA8806501A1 (en) | TRIAZOLOTRIAZINAS AND TRIAZOLOPIRAZINAS AND ITS USE | |
| MX2010003772A (en) | 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1. | |
| GT200600369A (en) | PROCESS | |
| UY28248A1 (en) | CHINICAL COMPOUNDS | |
| AR058173A1 (en) | USE OF SDF-1 FOR THE TREATMENT AND / OR PREVENTION OF NEUROLOGICAL DISEASES | |
| AR053775A1 (en) | NONADEPSIPEPTIDES ACILATED II | |
| ECSP109874A (en) | NEW COMPOUNDS 892 | |
| ITMI20050261A1 (en) | STRUCTURAL ANALOGS OF AVENATRAMIDS THEIR USE IN USEFUL COMPOSITIONS IN THE TREATMENT OF DERMATOLOGICAL DISORDERS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |